Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03449381
Title This Study Aims to Find the Best Dose of BI 907828 in Patients With Different Types of Advanced Cancer (Solid Tumors)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Boehringer Ingelheim
Indications

glioblastoma

sarcoma

lung non-squamous non-small cell carcinoma

Advanced Solid Tumor

transitional cell carcinoma

Therapies

BI 907828

Age Groups: adult | senior
Covered Countries USA | ESP | DEU | CAN | BEL

Additional content available in CKB BOOST